Sanofi's Lantus targeted by Novo, Lilly; HGS shareholder sues over poison pill;

 @FiercePharma: Remember that U.K. recall where Seroquel packs got into boxes of a popular painkiller? The perp is in jail for 18 months. Story | Follow @FiercePharma

> Novo Nordisk ($NVO) and Eli Lilly ($LLY) are preparing to take aim at Sanofi's ($SNY) blockbuster diabetes treatment Lantus, with Novo's new medication awaiting possible FDA approval this summer. Report

> A Human Genome Sciences ($HGS) shareholder has sued the company over the poison pill adopted to fend off a $2.6 billion hostile bid from GlaxoSmithKline ($GSK) ; GSK has said it won't go forward unless HGS drops the measure. News

> The FDA is appealing a court order that banned importation of sodium thiopental, a drug used in lethal injections as well as for medical reasons. Item

> A U.K. schizophrenia patient who inserted blister packs of the antipsychotic Seroquel into boxes of Nurofen Plus to feed his painkiller habit, prompting a nationwide recall, was jailed for 18 months. Story

> South Africa-based Adcock Ingram reported a 10% drop in half-year earnings after the loss of high-margin products to safety concerns. Article

Biotech News

 @FierceBiotech: 23andMe stakes a claim on Parkinson's gene. More | Follow @FierceBiotech

 @RyanMFierce: Which data analysis provider does Vertex blame for misinterpreting CF results? Seems like a big dropped ball. | Follow @RyanMFierce

 @JohnCFierce: Phase III starts in June: Sanofi/Regeneron add to stockpile of promising PCSK9 LDL drug data. Item | Follow @JohnCFierce

> Bungled analysis forces Vertex to revise cystic fibrosis drug data. News

> Lilly backs $150M Montreal biotech fund for single-project startups. Story

> Insider accounts spur a reported bidding war for Amylin. Article

> Senator takes a stab at repeating biotech R&D credit program. More

Medical Devices News

 @FierceMedDev: Arizona State researchers are working with NASA to develop a way to diagnose bone loss by testing calcium in urine. Story | Follow @FierceMedDev

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Boston Scientific's GI balloon dilator gains expanded FDA nod. Report

> Investors pursue medical devices that can do a drug's job. News

> FDA wants reanalysis of St. Jude heart implant. Item

> Siemens victory stands in ruling over PET scanner imaging crystal patents. Article

Pharma Manufacturing News

> Drug shortages deepen as Pakistan debates price controls. Story

> Ranbaxy hires U.S. consultants under consent decree. Report

> Hospira overfills far greater than first thought. More

> As manufacturing capacity halves, CMO revenue could double in Europe. Analysis

Biotech IT News

> BGI and Big Pharma probe trigger of liver cancer. Article

> 23andMe stakes a claim on Parkinson's gene. Item

> Roche re-enlists software for personalized medicine research. News

> Broken link found in electronic clinical trial startups. Report

Biotech Research News

> Scientists decipher how T cells hunt down infection. Story

> Embyronic stem cells treat neuropathic pain in preclinical success. More

> New peptide compound triggers enhanced tumor cell death. News

> Dangerous antipsychotic shows leukemia-fighting promise in mice. Article

And Finally... Mayo Clinic sciences went to Mount Everest to study the effects of high altitude on mountain climbers, hoping for insights into heart failure and other conditions. Report